Long-term Treatment of Scalp Psoriasis With Xamiol® Gel in a Large Adult Chinese Population
Status:
Completed
Trial end date:
2018-03-06
Target enrollment:
Participant gender:
Summary
A phase 4 trial comparing the safety and efficacy of treatment with Xamiol® gel (calcipotriol
50 mcg/g plus betamethasone 0.5 mg/g (as dipropionate)) once daily (as required) with
Daivonex® scalp solution (calcipotriol 50 mcg/g) twice daily (as required) in Chinese
subjects with scalp psoriasis